153 related articles for article (PubMed ID: 31997047)
1. Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study.
Kalamo MH; Mäenpää JU; Seppälä TT; Mecklin JP; Huhtala H; Sorvettula K; Pylvänäinen K; Staff S
Fam Cancer; 2020 Apr; 19(2):177-182. PubMed ID: 31997047
[TBL] [Abstract][Full Text] [Related]
2. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
3. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.
Burke W; Petersen G; Lynch P; Botkin J; Daly M; Garber J; Kahn MJ; McTiernan A; Offit K; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(11):915-9. PubMed ID: 9062331
[TBL] [Abstract][Full Text] [Related]
5. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
[TBL] [Abstract][Full Text] [Related]
6. Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.
Yurgelun MB; Mercado R; Rosenblatt M; Dandapani M; Kohlmann W; Conrad P; Blanco A; Shannon KM; Chung DC; Terdiman J; Gruber SB; Garber JE; Syngal S; Stoffel EM
Gynecol Oncol; 2012 Dec; 127(3):544-51. PubMed ID: 22940489
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic hysterectomy in Lynch syndrome: Feasibility and outcomes].
Pacelli J; Gosset M; Rossi L; Ngo C; Delomenie M; Nos C; Lécuru F; Bats AS
Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):497-503. PubMed ID: 31003015
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
9. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial consequences of predictive genetic testing for Lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study.
Aktan-Collan K; Kääriäinen H; Järvinen H; Peltomäki P; Pylvänäinen K; Mecklin JP; Haukkala A
Fam Cancer; 2013 Dec; 12(4):639-46. PubMed ID: 23512527
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Lynch Syndrome Mismatch Repair Genes in Women with Endometrial Cancer.
Rubio I; Ibáñez-Feijoo E; Andrés L; Aguirre E; Balmaña J; Blay P; Llort G; González-Santiago S; Maortua H; Tejada MI; Martinez-Bouzas C
Oncology; 2016; 91(3):171-6. PubMed ID: 27398995
[TBL] [Abstract][Full Text] [Related]
12. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
13. Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers.
Etchegary H; Dicks E; Tamutis L; Dawson L
Fam Cancer; 2018 Jan; 17(1):53-61. PubMed ID: 28551770
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families.
Auranen A; Joutsiniemi T
Acta Obstet Gynecol Scand; 2011 May; 90(5):437-44. PubMed ID: 21306348
[TBL] [Abstract][Full Text] [Related]
15. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
16. Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome.
Karamurzin Y; Soslow RA; Garg K
Am J Surg Pathol; 2013 Apr; 37(4):579-85. PubMed ID: 23426126
[TBL] [Abstract][Full Text] [Related]
17. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.
Boilesen AE; Bisgaard ML; Bernstein I
Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272
[TBL] [Abstract][Full Text] [Related]
18. Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients.
Brand RE; Dudley B; Karloski E; Das R; Fuhrer K; Pai RK; Pai RK
Fam Cancer; 2020 Apr; 19(2):169-175. PubMed ID: 31997046
[TBL] [Abstract][Full Text] [Related]
19. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F
Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
